ABFERO PHARMACEUTICALS
Abfero Pharmaceuticals is a clinical-stage pharmaceutical company that specializes in the healthcare and medical industry. The company focuses exclusively on iron as a therapeutic target, its mission is to develop novel therapies for the treatment of iron-overload conditions. It was founded in 2016 and headquartered in Lexington, Massachusetts.
ABFERO PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2016-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.abferopharmaceuticals.com
Total Employee:
1+
Status:
Active
Total Funding:
6.68 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical companyย focused on theย prevention and treatment of gastrointestinal disorders.
Current Employees Featured
Founder
Investors List
DeepWork Capital
DeepWork Capital investment in Seed Round - Abfero Pharmaceuticals
DeepWork Capital
DeepWork Capital investment in Seed Round - Abfero Pharmaceuticals
Official Site Inspections
http://www.abferopharmaceuticals.com
- Host name: box2378.bluehost.com
- IP address: 50.87.170.207
- Location: Provo United States
- Latitude: 40.2342
- Longitude: -111.6442
- Metro Code: 770
- Timezone: America/Denver
- Postal: 84606

More informations about "Abfero Pharmaceuticals"
Abfero Pharmaceuticals | Iron as a Therapeutic Target
Our mission. Abfero Pharmaceuticals Inc. is a clinical stage pharmaceutical company focused exclusively on iron as a therapeutic target. Our mission is to develop best-in-class oral iron โฆSee details»
Abfero Pharmaceuticals - Crunchbase Company Profile โฆ
Abfero Pharmaceuticals is a clinical-stage pharmaceutical company that specializes in the healthcare and medical industry. The company focuses โฆSee details»
Abfero Pharmaceuticals, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Abfero Pharmaceuticals, Inc. of Boston, MA. Get the latest business insights from Dun & Bradstreet.See details»
AbFero Pharmaceuticals, Inc. | LinkedIn
AbFero Pharmaceuticals is a privately-held clinical stage pharmaceutical company dedicated to treating diseases of iron overload. Our therapeutic platform addresses transfusion-related iron ...See details»
Abfero Pharmaceuticals Company Profile | Management and
Www.abferopharmaceuticals.com . Abfero Pharmaceuticals Profile and History. AbFero Pharmaceuticals, Inc. is a privately-held clinical stage pharmaceutical company dedicated to โฆSee details»
PHARMACOSMOS GROUP ACQUIRES BOSTON BASED CLINICAL โฆ
Visit: https://www.abferopharmaceuticals.com. Pharmacosmos Contact Information Tobias S. Christensen, COO +45 5948 5959, [email protected]. Title: Press-Release โฆSee details»
Pharmacosmos Group Acquires Boston Based Clinical Stage โฆ
Nov 11, 2021 For more information, visit: https://www.abferopharmaceuticals.com. Pharmacosmos Contact Information Tobias S. Christensen, COO +45 5948 5959, [email โฆSee details»
Abfero Pharmaceuticals - PitchBook
Www.abferopharmaceuticals.com. Ownership Status. Acquired/Merged (Operating Subsidiary) Financing Status. Formerly VC-backed. Corporate Office. 867 Boylston Street; Floor 5; โฆSee details»
Contact - Abfero Pharmaceuticals
AbFero Pharmaceuticals has been acquired by Pharmacosmos. Pharmacosmos is specialized in iron metabolism. Our website is for general information purposes only.See details»
Abfero Pharmaceuticals - Craft
See insights on Abfero Pharmaceuticals including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
AbFero Pharmaceuticals - Products, Competitors, Financials, โฆ
Headquarters Location. 405 Waltham Street Suite 353. Lexington, Massachusetts, 02421, United States. 781-266-7297See details»
Overview, News & Similar companies - ZoomInfo.com
Feb 16, 2021 www.abferopharmaceuticals.com. Revenue <$5 Million. Industry Drug Stores & Pharmacies Retail . Recent News & Media. AbFero Pharmaceuticals Announces Initiation Of โฆSee details»
Acquisition of UF Faculty Startup AbFero Provides Iron Chelators โฆ
Nov 16, 2021 website builders Removing excess iron may provide therapeutic relief for macular degeneration, Parkinsonโs, and more. Late last week, Danish biotech Pharmacosmos โฆSee details»
News - Abfero Pharmaceuticals
Nov 11, 2021 Latest News from Abfero Pharmaceuticals. Boston, MA (May 20, 2021) โ AbFero Pharmaceuticals, Inc., a privately-held clinical stage pharmaceutical company dedicated to โฆSee details»
AbFero Pharmaceuticals Announces Funding From Cure โฆ
HARWELL, England, Feb. 17, 2021 /PRNewswire/ -- AbFero Ltd., a subsidiary of AbFero Pharmaceuticals, Inc., a privately-held clinical stage pharmaceutical company dedicated to โฆSee details»
AbFero to Receive โฌ 2M Eurostars Funding for Parkinson's Disease ...
Dec 1, 2020 Clinical stage pharmaceutical company forms multi-national research consortium to establish iron chelating compounds as disease modifying therapy ...See details»
AbFero EUREKA Eurostars - abferopharmaceuticals.com
Www.abferopharmaceuticals.com. Investor & Media Contact: Mih-Ho Cha [email protected] . Title: AbFero EUREKA Eurostars Created Date: 11/30/2020 10:27:16 PM ...See details»
Pipeline - Abfero Pharmaceuticals
Our therapeutic platform addresses transfusional iron overload (TIO) and iron accumulation associated with diseases of aging. With SP-420โs ability to cross the blood-brain and blood โฆSee details»
AbFero to Receive โฌ 2M Eurostars Funding for Parkinson's Disease โฆ
HARWELL, England, Dec. 1, 2020 /PRNewswire/ -- AbFero Ltd., a subsidiary of AbFero Pharmaceuticals, Inc., a privately-held clinical stage pharmaceutical company dedicated to โฆSee details»
20210217 AbFero Cure Parkinson's Grant [Final]
Www.abferopharmaceuticals.com. Investor & Media Contact: Mih-Ho Cha [email protected]. Title: 20210217 AbFero Cure Parkinson's Grant [Final] Created Date:See details»